My Legacy Advisors LLC Cuts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

My Legacy Advisors LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 31.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,834 shares of the company’s stock after selling 1,775 shares during the quarter. My Legacy Advisors LLC’s holdings in HCA Healthcare were worth $1,558,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at about $28,000. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth about $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded down $1.95 on Tuesday, hitting $408.81. 425,650 shares of the company’s stock were exchanged, compared to its average volume of 1,135,621. The stock has a market capitalization of $107.07 billion, a PE ratio of 20.27, a PEG ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The company has a 50-day simple moving average of $393.16 and a 200-day simple moving average of $351.09.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the prior year, the firm earned $4.29 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on HCA. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Barclays increased their price target on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Royal Bank of Canada increased their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Finally, UBS Group raised their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $367.15.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.